International Stem Cell Corporation Provides Strategic Update on the Company’s Cornea Transplantation Program
OCEANSIDE, Calif.—-International Stem Cell Corporation , www.intlstemcell.com, announced today that multiple international meetings taking place between ISCO’s executive management and researchers and clinicians from commercial entities in both Asia and Europe revealed significant clinical-commercial opportunities for the company’s stem cell-derived human cornea …
[Read the full article here]Related News:
International Stem Cell’s human cornea technology: Clinical-commercial opportunities in Asia and Europe
International Stem Cell Corporation Moves International Cornea Development Program Forward
International Stem Cell Corporation Files for Cornea Transplantation …